PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · IEX Real-Time Price · USD
33.62
-0.54 (-1.58%)
At close: May 2, 2024, 4:00 PM
33.59
-0.03 (-0.09%)
Pre-market: May 3, 2024, 4:25 AM EDT
PTC Therapeutics Employees
PTC Therapeutics had 995 employees on December 31, 2023. The number of employees decreased by 415 or -29.43% compared to the previous year.
Employees
995
Change (1Y)
-415
Growth (1Y)
-29.43%
Revenue / Employee
$932,219
Profits / Employee
-$582,132
Market Cap
2.58B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 995 | -415 | -29.43% |
Dec 31, 2022 | 1,410 | 233 | 19.80% |
Dec 31, 2021 | 1,177 | 210 | 21.72% |
Dec 31, 2020 | 967 | 206 | 27.07% |
Dec 31, 2019 | 761 | 244 | 47.20% |
Dec 31, 2018 | 517 | 144 | 38.61% |
Dec 31, 2017 | 373 | 69 | 22.70% |
Dec 31, 2016 | 304 | -16 | -5.00% |
Dec 31, 2015 | 320 | 127 | 65.80% |
Dec 31, 2014 | 193 | 56 | 40.88% |
Dec 31, 2013 | 137 | 16 | 13.22% |
Dec 31, 2012 | 121 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
ICU Medical | 14,000 |
Premier | 2,800 |
Neogen | 2,640 |
Inari Medical | 1,300 |
MorphoSys AG | 524 |
Corcept Therapeutics | 352 |
Rhythm Pharmaceuticals | 226 |
Celldex Therapeutics | 160 |
PTCT News
- 23 hours ago - PTC Therapeutics to Participate at Upcoming Investor Conferences - PRNewsWire
- 7 days ago - PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results - PRNewsWire
- 9 days ago - PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 21 days ago - PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results - PRNewsWire
- 5 weeks ago - PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA - PRNewsWire
- 5 weeks ago - PTC Therapeutics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- PTCT - Accesswire
- 5 weeks ago - PTC Therapeutics, Inc. (PTCT) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates - Accesswire
- 5 weeks ago - PTCT ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your PTC Therapeutics, Inc. investment - Accesswire